rs3211371

Variant summary

Our verdict is Likely benign.
-6 Likely Benign
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received -6 classification points (ACMG Germline Pathogenicity v2019). BS2BP4_Moderate

The NM_000767.5(CYP2B6):c.1459C>A (p.Arg487Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a cumulative frequency of 0.0000713 (AC=115) in the gnomAD database across 1,613,602 control chromosomes (no homozygotes observed). The grpmax filtering allele frequency (95% CI) is 0.0013. In-silico predictor (REVEL) classifies this variant as likely benign. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.00034 ( 0 hom., cov: 31)
Exomes 𝑓: 0.000044 ( 0 hom. )

Consequence

CYP2B6
NM_000767.5 missense

Scores

19

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.846

Publications

2 publications found
Variant links:
Genes affected
CYP2B6 (HGNC:2615): (cytochrome P450 family 2 subfamily B member 6) This gene, CYP2B6, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to metabolize some xenobiotics, such as the anti-cancer drugs cyclophosphamide and ifosphamide. Transcript variants for this gene have been described; however, it has not been resolved whether these transcripts are in fact produced by this gene or by a closely related pseudogene, CYP2B7. Both the gene and the pseudogene are located in the middle of a CYP2A pseudogene found in a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_000767.5, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACMG Germline Pathogenicity v2019

Classification was made for transcript:

Our verdict: Likely_benign. The variant received -6 points.

BP4Computational evidence suggests no impact
Computational evidence supports benign — no pathogenic computational or splicing signal (BP4); Splicing verdict: benign (Strong).; Germline computational verdict: benign (Moderate).
BS2Observed in healthy adult
Pure AD gene with cumulative gnomAD AC ≥5 — observed in healthy adults (BS2); GnomAD homozygous count = 0.; Very high cumulative gnomAD AC = 115 (any gene).

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_000767.5. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

CYP2B6 NM_000767.5
MANE Select
HGVSc / HGVSpc.1459C>Ap.Arg487Ser
Exon rankExon 9 of 9
missense
Prot: NP_000758.1UniProt: P20813-1

Ensembl Transcripts

CYP2B6 ENST00000324071.10
TSL:1MANE Select
HGVSc / HGVSpc.1459C>Ap.Arg487Ser
Exon rankExon 9 of 9
missense
Prot: ENSP00000324648.2UniProt: P20813-1
CYP2B6 ENST00000597612.1
TSL:1
HGVSc / HGVSpn.812C>A
Exon rankExon 3 of 3
non_coding_transcript_exon
Prot:
CYP2B6 ENST00000863358.1
HGVSc / HGVSpc.1114C>Ap.Arg372Ser
Exon rankExon 7 of 7
missense
Prot: ENSP00000533417.1UniProt: A0ACI8QFV7

Frequencies

Allele frequencies (AF), counts (AC/AN), homozygotes and coverage

Common (AF > 0.05 / Hom > 5)
Rare (AF ≤ 0.0001 / Hom ≤ 1)
Global population databases 6 sources
GnomAD3 genomes
AF: 0.000329
AC:50
Hom:0
AN:152096
Cov:31
GnomAD2 exomes
AF: 0.000120
AC:30
AN:250440
GnomAD4 exome
AF: 0.0000438
AC:64
Hom:0
AN:1461388
Cov:32
GnomAD4 genome
AF: 0.000335
AC:51
Hom:0
AN:152214
Cov:31
TOPMed (Bravo)
AF: 0.000416
ALFA (dbGaP/dbSNP Allele Frequency Aggregator)
AF: 0.0000356
AC:2
Hom:285
AN:56180
Showing 6 sources

Case/control cohorts

CohortCasesControls
AFACANAFACAN
Epi25
(Epilepsy)
0.000143 641956 0.000135 966882
SCHEMA
(Schizophrenia)
0.000246 29117668 0.000303 61201322
Showing 2 cohortsAllele count / allele number. AF is computed from the counts for ASC (not provided by the source).

ClinVar

Not reported in ClinVar

Computational Scores

AlphaGenome AVI
Uncertain12
AlphaMissense
Benign0.24
BayesDel_addAF
Benign-0.55T
BayesDel_noAF
Benign-0.58
CADD
Benign0.93
DANN
Benign0.61
DEOGEN2
Benign0.0045T
Eigen
Benign-1.6
Eigen_PC
Benign-1.6
FATHMM_MKL
Benign0.018N
FuncVEP CTI
Benign0.033
GPN-Star LLR
N/A-4.3
GPN-Star score
N/A4.3
LIST_S2
Benign0.34T
M_CAP
Benign0.0073T
MetaRNN
Benign0.018T
MetaSVM
Benign-1.0T
Mutation Taster
N/A82/18polymorphism
MutationAssessor
Benign0.39N
PhyloP100
Benign-0.85
popEVE
Benign-2.4
PrimateAI
Benign0.20T
PROVEAN
Benign0.83N
REVEL
Benign0.027
Sift
Benign0.48T
Sift4G
Benign0.57T
Varity_R
N/A0.46
VESM-3B
Benign-5.7
Showing 28 of 28 scores

Splicing Scores

Pangolin (max)
Benign0.0
SpliceAI score (max)
Benign0.0
Details are displayed if max score is > 0.2
Showing 2 of 2 scores

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

MaveDB functional evidence

MaveDB is a public repository of laboratory assays that test the effect of thousands of variants at once — treat this as supporting research data and interpret it with great caution; it is not a clinical classification.

No MaveDB functional evidence found for this variant.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.